Clinical trial
Annual Study to Investigate Influenza Vaccine Due to New Virus Strains for the…
NCT00479921 · Solvay Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00479921 |
|---|---|
| Title | Annual Study to Investigate Influenza Vaccine Due to New Virus Strains for the 2007/2008 Influenza Season in Europe |
| Official title | Immunogenicity and Reactogenicity of Trivalent Influenza Subunit Vaccine Influvac® for the Season 2007/2008. An Open, Baseline-Controlled Multi-Center Study in Two Groups of Healthy Subjects: Adults and Elderly |
| Lead sponsor | Solvay Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Healthy Volunteers |
| Intervention type | Biological |
| Interventions | Trivalent influenza subunit vaccine |
| Enrollment | 120 |
| Start date | Jun 1, 2007 |
| First posted | May 30, 2007 |
| Last update posted | Jan 30, 2009 |
| Countries | Belgium, Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: